-
Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage ClosureL Asmarats, G O'Hara, J Champagne et al. -
Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy: 5-year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) StudyPC Block, Steven Burstein, Paul N Casale
-
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Results From the CABANA TrialDL Packer, JP Piccini, CABANA Investigators et al.
-
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight CommitteeGF Tomaselli, KW Mahaffey, A Cuker et al.
-
2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal OverviewMasoudi FA, Calkins H, Kavinsky CJ.
-
Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasomeY Zhang, S Zhang 1 , BL Li et al.
-
Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolationI Kawamura, P Neuzil, P Shrivamurthy et al.
-
Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantationY Choi, Y Lee, Y-S Oh et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
